ABCC1 p.Asn1156Gln
[switch to full view]Comments [show]
None has been submitted yet.
PMID: 9295302
[PubMed]
Hipfner DR et al: "Membrane topology of the multidrug resistance protein (MRP). A study of glycosylation-site mutants reveals an extracytosolic NH2 terminus."
No.
Sentence
Comment
66
The N19Q, N1006Q, and N1156Q mutations were generated using the TransformerTM site-directed mutagenesis kit (CLONTECH Laboratories, Inc., Palo Alto, CA) based on the method developed by Deng and Nickoloff (35).
X
ABCC1 p.Asn1156Gln 9295302:66:22
status: NEW67 The templates for mutagenesis were prepared by cloning the BamHI fragment as above (for N19Q) and the XmaI fragment (MRP nucleotides 2337-4322) (for N1006Q and N1156Q) from pcDNAI-MRP1 into pGEM®-3Z (Promega, Madison, WI).
X
ABCC1 p.Asn1156Gln 9295302:67:22
status: NEWX
ABCC1 p.Asn1156Gln 9295302:67:160
status: NEW68 Mutagenesis was then performed according to the manufacturer`s instructions using the ScaI/ StuI and SspI/EcoRV selection primers (for N19Q and N1006Q/N1156Q mutations, respectively), and the following sense mutagenic oligonucleotide primers: 5Ј-C TGG GAC TGG CAG GTC ACG TGG-3Ј (N19Q), 5Ј-C CCC ATC GTC CAG GGG ACT CAG G-3Ј (N1006Q), and 5Ј-C TAT TCC CAT TTC CAG GAG ACC TTG C-3Ј (N1156Q).
X
ABCC1 p.Asn1156Gln 9295302:68:151
status: NEWX
ABCC1 p.Asn1156Gln 9295302:68:160
status: NEWX
ABCC1 p.Asn1156Gln 9295302:68:418
status: NEW69 The N19Q/N23Q double mutant was also generated by this method using the N19Q mutagenic primer with the N23Q BamHI fragment in pGEM-3Z as a template.
X
ABCC1 p.Asn1156Gln 9295302:69:151
status: NEWX
ABCC1 p.Asn1156Gln 9295302:69:382
status: NEW172 We next examined expression of the MSD3 glycosylation acceptor site mutants MRP-(N1006Q) and MRP-(N1156Q).
X
ABCC1 p.Asn1156Gln 9295302:172:98
status: NEW173 The MRP-(N1156Q) mutant co-migrated with the wild-type protein, whereas MRP-(N1006Q) displayed a greater electrophoretic mobility (Fig. 4A, lanes 2, 7 and 8).
X
ABCC1 p.Asn1156Gln 9295302:173:9
status: NEW174 The C-1 fragments derived from wild-type MRP and MRP-(N1156Q) also co-migrated, and the C-1 fragment of MRP-(N1006Q) had the same electrophoretic mobility as the PNGaseF-treated wild-type C-1 fragment (Fig. 4C, lanes 1-4).
X
ABCC1 p.Asn1156Gln 9295302:174:54
status: NEW178 A, crude membrane proteins from Cos-1 cells expressing wild-type MRP (WT) treated with (ϩ) or without (-) PNGase F, the single glycosylation site mutant MRP constructs N19Q, N23Q, N71Q, N1006Q, and N1156Q, the double mutant N19Q/N23Q, and the triple mutant N19Q/N23Q/N1006Q were separated by SDS-polyacrylamide gel electrophoresis on 5% gels and immunoblotted with mAb QCRL-1.
X
ABCC1 p.Asn1156Gln 9295302:178:198
status: NEW231 On the other hand, it was expected that the MRP-(N1156Q) mutant might be informative because this asparagine residue is predicted to be extracytoplasmic only in the MSD3 configurations with four transmembrane segments.
X
ABCC1 p.Asn1156Gln 9295302:231:49
status: NEW